Natural killer (NK) cells are a subset of lymphocytes in humans that release cytokines such as tumor necrosis factor alpha and interferon gamma-γ during infection. NKG2D is one of the most important stimulating NK receptors binding MIC-A, MIC-B, and ULBPs, which leads to activation of NK cells against tumor cells. In this study, the authors evaluated the effect of G2 adjuvant on gene expression and delivery of NKG2D receptor on NK cells in peripheral blood.
Materials and Methods:
Peripheral blood mononuclear cells were isolated from venous blood obtained from healthy volunteers after adding G2 adjuvant within 12, 24, and 48 hours of incubation. Then, total RNA was extracted from the cells, cDNA synthesis was performed, and gene expression was evaluated by real-time PCR. In addition, NK cells were stained with the appropriate monoclonal antibodies, and the receptors expressed on cell surface were quantified.
Results:
G2 adjuvant leads to upregulation of gene expression and increases the expression of NKG2D receptor on the surface of NK cells after incubation.
Conclusion:
The findings of this study demonstrated that G2 adjuvant can increase NK cell cytotoxicity. It may play an important role in killing tumor cells, preventing tumor growth and metastasis.
Get full access to this article
View all access options for this article.
References
1.
BelloraF, CastriconiR, DonderoA, et al.Human NK cells and NK receptors. Immunol Lett, 2014; 161:168–173.
2.
CampbellKS, HasegawaJ. Natural killer cell biology: An update and future directions. J Allergy Clin Immunol, 2013; 132:536–544.
3.
KnorrDA, BachanovaV, VernerisMR, et al.Clinical utility of natural killer cells in cancer therapy and transplantation. Semin Immunol, 2014; 26:161–172.
4.
JohanssonS, HallH, BergL, HöglundP. NK cells in autoimmune disease. In: Immunobiology of Natural Killer Cell Receptors. Springer, 2006; 259–277.
5.
FerlazzoG, ThomasD, LinS-L, et al.The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol, 2004; 172:1455–1462.
6.
DiSantoJP, MüllerW, Guy-GrandD, et al.Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A, 1995; 92:377–381.
7.
SojkaDK, TianZ, YokoyamaWM. Tissue-resident natural killer cells and their potential diversity. Semin Immunol, 2014; 26:127–131.
8.
SunPD. Structure and function of natural-killer-cell receptors. Immunol Res, 2003; 27:539–548.
9.
WuL, ZhangC, TianZ, ZhangJ. NK cell-based approach for screening novel functional immune genes. Int Immunopharmacol, 2011; 11:274–279.
10.
MacFarlaneIV A, CampbellK. Signal transduction in natural killer cells. In: Immunobiology of Natural Killer Cell Receptors. Springer, 2006; 23–57.
BrittendenJ, HeysS, RossJ, et al.Natural killer cells and cancer. Cancer, 1996; 77:1226–1243.
13.
WuJ, LanierLL. Natural killer cells and cancer. Adv Cancer Res, 2003; 90:127–156.
14.
SatoE, OlsonSH, AhnJ, et al.Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A, 2005; 102:18538–18543.
15.
WhitesideTL, HerbermanRB. The role of natural killer cells in immune surveillance of cancer. Curr Opin Immunol, 1995; 7:704–710.
16.
NeamatiA, BoskabadyMH, AfshariJT, et al.The effect of natural adjuvants on tracheal responsiveness and cell count in lung lavage of sensitized guinea pigs. Respirology, 2009; 14:877–884.
17.
FussIJ, KanofME, SmithPD, et al.Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr Protoc Immunol, 2009;Chapter 7: Unit 7.1.
18.
HadaddezfuliR, KhodadadiA, AssarehzadeganM-A, et al.Hemiscorpius lepturus venom induces expression and production of interluckin-12 in human monocytes. Toxicon, 2015; 100:27–31.
19.
GrohV, BrühlA, El-GabalawyH, et al.Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A, 2003; 100:9452–9457.
20.
Mohaghegh HazratiS, editor. A Novel an Invasive and Metastatic Adenocarcinoma of Breast Cancer (HAZ-1) in Small White Laboratory Mice (Complementary Report). The Fifth Biochemistry Congress of Uromia, IR of Iran, September 6–9, 1999.
21.
Mohaghegh HazratiS, Nasiri KhalajS, MohtaramiF. Phase I & II Results of Clinical Trail of T helper-1 Cell Activators (G2, PC, G2F) as Adjuvants on Asthma (Biotherapy of Asthma). Third National Conference of Biotechnology in Mashad, Iran, September 2003.
22.
NeamatiA, BoskabadyMH, HazratiSM, et al.The effect of natural adjuvants (G2, G2F) on lung inflammation of sensitized guinea pigs. Avicenna J Phytomed, 2013; 3:364–370.
23.
NeamatiA, BoskabadyMH, TabatabaeiA, et al.The effect of natural adjuvants on pathological changes in sensitized Guinea Pig Lungs. Iran Red Crescent Med J, 2014; 16:e14267.
24.
JohnA, TuszynskiG. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Patholo Oncol Res, 2001; 7:14–23.
25.
SauerCG, KappelerA, SpathM, et al.Expression and activity of matrix metalloproteinases-2 and −9 in serum, core needle biopsies and tissue specimens of prostate cancer patients. Virchows Arch, 2004; 444:518–526.
26.
BudkowskaA, MaillardP, TheretN, et al.Activation of the envelope proteins by a metalloproteinase enables attachment and entry of the hepatitis B virus into T-lymphocyte. Virology, 1997; 237:10–22.
27.
HazratiSM, AghazadehJ, MohtaramiF, et al.Immunotherapy of prolactinoma with a T helper 1 activator adjuvant and autoantigens: A case report. Neuroimmunomodulation, 2005; 13:205–208.
28.
RansonT, VosshenrichCA, CorcuffE, et al.IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood, 2003; 101:4887–4893.
29.
Arreygue-GarciaNA, Daneri-NavarroA, del Toro-ArreolaA, et al.Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions. BMC Cancer, 2008; 8:16.
30.
Mincheva-NilssonL, BaranovV. Cancer exosomes and NKG2D receptor-ligand interactions: Impairing NKG2D-mediated cytotoxicity and anti-tumour immune surveillance. Semin Cancer Biol, 2014; 28:24–30.
31.
JamiesonA, DiefenbachA, McMahonC, et al.The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity, 2004; 20:799.
32.
OsadaT, ClayT, HobeikaA, et al.NK cell activation by dendritic cell vaccine: A mechanism of action for clinical activity. Cancer Immunol Immunother, 2006; 55:1122–1131.
33.
LionE, SmitsEL, BernemanZN, et al.NK cells: Key to success of DC-based cancer vaccines?. Oncologist, 2012; 17:1256–1270.
34.
WhitmanE, BarberA. NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8+ T cells. Mol Immunol, 2015; 63:268–278.
ZhangC, ZhangJ, NiuJ, et al.Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation. Cytokine, 2008; 42:128–136.
37.
ZhouH, LuoY, LoJ-F, et al.DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor. Proc Natl Acad Sci U S A, 2005; 102:10846–10851.
38.
ÖzdemirÖ, RavindranathY, SavasanS. Mechanisms of superior anti-tumor cytotoxic response of interleukin 15-induced lymphokine-activated killer cells. J Immunother, 2005; 28:44–52.
39.
WallinR, ScrepantiV, MichaëlssonJ, et al.Regulation of perforin-independent NK cell-mediated cytotoxicity. Eur J Immunol, 2003; 33:2727–2735.
40.
ScrepantiV, WallinRP, GrandienA, et al.Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells. Mol Immunol, 2005; 42:495–499.
41.
JeongSK, YangK, ParkYS, et al.Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages. Int Immunopharmacol, 2014; 22:303–310.
42.
BuhtoiarovIN, RakhmilevichAL, LanierLL, et al.Naive mouse macrophages become activated following recognition of L5178Y lymphoma cells via concurrent ligation of CD40, NKG2D, and CD18 molecules. J Immunol, 2009; 182:1940–1953.
43.
SicaA, SchioppaT, MantovaniA, et al.Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy. Eur J Cancer, 2006; 42:717–727.
44.
LjunggrenH-G. Cancer immunosurveillance: NKG2D breaks cover. Immunity, 2008; 28:492–494.
45.
RoshaniR, Ghafourian BoroujerdniaM, TalaiezadehAH, et al.Assessment of changes in expression and presentation of NKG2D under influence of MICA serum factor in different stages of breast cancer. Tumor Biol, 2015; DOI: 10.1007/s13277-015-4584-7
46.
HaoS, ZhaoJ, ZhouJ, et al.Modulation of 17β-estradiol on the number and cytotoxicity of NK cells in vivo related to MCM and activating receptors. Int Immunopharmacol, 2007; 7:1765–1775.
